---
title: "Mounjaro (tirzepatide) in type 2 diabetes: Dosing and administration questions"
description: "Dosing and administration questions on Mounjaro (tirzepatide) in type 2 diabetes, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Administration and Dosing. Questions: Can Mounjaro be used with insulin? What is the Mounjaro dosing schedule for adults? What is the maximum dose of Mounjaro? What is the Mounjaro dose for children 10 years and older? 4 questions quoted from 3 sources."
canonical: "https://www.evicenter.com/medical-information/mounjaro--type-2-diabetes/dosing-and-administration"
published: "2026-11-12T22:05:36-05:00"
modified: "2026-11-14T16:49:54-05:00"
---

# Mounjaro (tirzepatide) in type 2 diabetes: Dosing and administration questions

Manufacturer: Lilly USA, LLC  
Prescribing information: [Mounjaro](https://uspl.lilly.com/mounjaro/mounjaro.html#pi)

Dosing and administration questions that apply to every indication of Mounjaro are on [Mounjaro (tirzepatide), all indications: Dosing and administration](https://www.evicenter.com/medical-information/mounjaro/dosing-and-administration).

## Administration

<a id="mounjaro-with-insulin"></a>

### Can Mounjaro be used with insulin?

Applies to: Glycemic control as an adjunct to diet and exercise in adults with type 2 diabetes mellitus

> “When using MOUNJARO with insulin, administer as separate injections and never mix. It is acceptable to inject MOUNJARO and insulin in the same body region, but the injections should not be adjacent to each other.”

Source: [MOUNJARO: Prescribing information, captured 2026-11-12](https://uspl.lilly.com/mounjaro/mounjaro.html#pi:~:text=When%20using%20MOUNJARO%20with%20insulin%2C,be%20adjacent%20to%20each%20other.)

> “When initiating MOUNJARO, consider reducing the dose of concomitantly administered insulin secretagogues (e.g., sulfonylureas) or insulin to reduce the risk of hypoglycemia [see Warnings and Precautions (5.3)].”

Source: [MOUNJARO: Prescribing information, captured 2026-11-12](https://uspl.lilly.com/mounjaro/mounjaro.html#pi:~:text=When%20initiating%20MOUNJARO%2C%20consider%20reducing,%5Bsee%20Warnings%20and%20Precautions%20%285.3%29%5D.)

## Dosing

<a id="mounjaro-dosing-adults"></a>

### What is the Mounjaro dosing schedule for adults?

Applies to: Glycemic control as an adjunct to diet and exercise in adults with type 2 diabetes mellitus

> “The recommended starting dosage of MOUNJARO is 2.5 mg injected subcutaneously once weekly [see Dosage and Administration (2.2)].
> If additional glycemic control is needed, increase the dosage in 2.5 mg increments after at least 4 weeks on the current dose.
> The maximum dosage of MOUNJARO is:
> 15 mg injected subcutaneously once weekly in adults.
> 10 mg injected subcutaneously once weekly in pediatric patients.”

Source: [MOUNJARO: Prescribing information, captured 2026-11-12](https://uspl.lilly.com/mounjaro/mounjaro.html#pi:~:text=The%20recommended%20starting%20dosage%20of,once%20weekly%20in%20pediatric%20patients.)

Note: The maximum dosage lines list adults and pediatric patients separately; the 15 mg maximum applies to adults.

<a id="mounjaro-max-dose"></a>

### What is the maximum dose of Mounjaro?

> “The maximum dosage of MOUNJARO is:
> 15 mg injected subcutaneously once weekly in adults.
> 10 mg injected subcutaneously once weekly in pediatric patients.”

Source: [MOUNJARO: Prescribing information, captured 2026-11-12](https://uspl.lilly.com/mounjaro/mounjaro.html#pi:~:text=The%20maximum%20dosage%20of%20MOUNJARO,once%20weekly%20in%20pediatric%20patients.)

> “The maximum dosage of Mounjaro is 15 mg injected subcutaneously once weekly in adults.”

Source: [MOUNJARO: Getting Started, Dosing & Prescribing, captured 2026-11-12](https://mounjaro.lilly.com/hcp/getting-patients-started#:~:text=The%20maximum%20dosage%20of%20Mounjaro,subcutaneously%20once%20weekly%20in%20adults.)

<a id="mounjaro-dosing-children"></a>

### What is the Mounjaro dose for children 10 years and older?

Applies to: Glycemic control as an adjunct to diet and exercise in pediatric patients 10 years of age and older with type 2 diabetes mellitus

> “The recommended starting dosage of Mounjaro is 2.5 mg injected subcutaneously once weekly.
> If additional glycemic control is needed, increase the dosage in 2.5 mg increments after at least 4 weeks on the current dose.
> The maximum dosage of Mounjaro is 10 mg injected subcutaneously once weekly for pediatric patients.”

Source: [MOUNJARO: PEDs, captured 2026-11-12](https://mounjaro.lilly.com/hcp/peds#:~:text=The%20recommended%20starting%20dosage%20of,once%20weekly%20for%20pediatric%20patients.)

> “Image depicting the dosing and escalation schedule for Mounjaro in pediatric patients. The recommended starting dose is 2.5 mg once weekly for at least 4 weeks. If additional glycemic control is needed, escalate in 2.5 mg increments to the 5 mg dose once weekly for at least 4 weeks, then 7.5 mg dose once weekly for at least 4 weeks, and finally the 10 mg dose once weekly as the maximum dose.”

Source: [MOUNJARO: PEDs, captured 2026-11-12](https://mounjaro.lilly.com/hcp/peds#:~:text=Image%20depicting%20the%20dosing%20and,weekly%20as%20the%20maximum%20dose.)

On the page, select: Image description

## Related pages
- [Medical information: Mounjaro (tirzepatide): Type 2 diabetes](https://www.evicenter.com/medical-information/mounjaro--type-2-diabetes)
- [Indication](https://www.evicenter.com/medical-information/mounjaro--type-2-diabetes/indication)
- [Clinical trials](https://www.evicenter.com/medical-information/mounjaro--type-2-diabetes/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/mounjaro--type-2-diabetes/safety)
- [Specific populations](https://www.evicenter.com/medical-information/mounjaro--type-2-diabetes/specific-populations)
- [Access and coverage](https://www.evicenter.com/medical-information/mounjaro--type-2-diabetes/access-and-coverage)
